Austin Health

Futó vizsgálatok

• Toboroz

  A Study of ARC-02 in B-cell NHL

  NCT07691606· 1. fázis· Forrás

• Toboroz

  Specific and Novel Approaches to Care of Inflammatory Bowel Disease During Pregnancy: the PREGO Study

  NCT07916727· Forrás

• Toboroz

  Study of TLX101-Tx Plus Standard of Care (SoC) Versus SoC Alone for the Treatment of Patients With Recurrent Glioblastoma

  NCT07100730· 3. fázis· Forrás

• Toboroz

  PRospective phenotypIng and Multi-omic Endotyping of Progressive Pulmonary Fibrosis

  NCT06855329· Forrás

• Fut, nem toboroz

  Optimising Metabolic Management for People With Human Immunodeficiency Virus (HIV) on Integrase Based Antiretroviral Therapy (ART)

  NCT06317051· 3. fázis· Forrás

• Toboroz

  Phase II Study of the Combination of Durvalumab (MEDI4736) (PDL1 Inhibitor) and Olaparib (PARP Inhibitor) in Advanced Cholangiocarcinoma After Initial Chemotherapy and Durvalumab (BIL-PPP)

  NCT06441747· 2. fázis· Forrás

• Még nem toboroz

  Electronic Capturing of Activities During REhabilitation for Upper Limb After Stroke

  NCT06527261· Forrás

• Toboroz

  Combination of 177Lu-TLX250 and Peposertib in Patients With Carbonic Anhydrase IX -Expressing Solid Tumors

  NCT05868174· 1. fázis· Forrás

• Toboroz

  A Randomized Study of XEN1101 Versus Placebo in Focal-Onset Seizures (X-TOLE3)

  NCT05716100· 3. fázis· Forrás

• Fut, nem toboroz

  Study of Sacituzumab Govitecan Versus Treatment of Physician's Choice in Patients With Hormone Receptor-positive/Human Epidermal Growth Factor Receptor 2 Negative (HR+/HER2-) Metastatic Breast Cancer Who Have Received Endocrine Therapy

  NCT05840211· 3. fázis· Forrás

• Fut, nem toboroz

  Combining Sodium Valproate With Standard-of-care EGFR (Epidermal Growth Factor Receptor) Monoclonal Antibody Treatment in Patients With Metastatic Colorectal Cancer

  NCT05694936· 2. fázis· Forrás

• Toboroz

  Implementation of Metformin theraPy to Ease Decline of Kidney Function in Polycystic Kidney Disease (IMPEDE-PKD)

  NCT04939935· 3. fázis· Forrás

• Fut, nem toboroz

  Phase 3 Study of Teclistamab in Combination With Lenalidomide and Teclistamab Alone Versus Lenalidomide Alone in Participants With Newly Diagnosed Multiple Myeloma as Maintenance Therapy Following Autologous Stem Cell Transplantation

  NCT05243797· 3. fázis· Forrás

• Toboroz

  The ElectRx Study - A Neurotechnology Approach to the Treatment of IBD

  NCT05469607· Forrás

• Fut, nem toboroz

  PSMA PET Additive Value for Prostate Cancer Diagnosis in Men With Negative/Equivocal MRI

  NCT05154162· 3. fázis· Forrás

• Fut, nem toboroz

  Chemotherapy and Immunotherapy in Extensive-Stage Small-Cell Lung Cancer With Thoracic Radiotherapy

  NCT05796089· 2. fázis· Forrás

• Toboroz

  Polysomnographic Titration of Non-invasive Ventilation in Motor Neurone Disease

  NCT05136222· Forrás

• Toboroz

  Adaptive RadioTherapy for OroPharynx Cancer

  NCT04901234· 2. fázis· Forrás

• Fut, nem toboroz

  In Men With Metastatic Prostate Cancer, What is the Safety and Benefit of Lutetium-177 PSMA Radionuclide Treatment in Addition to Chemotherapy

  NCT04343885· 2. fázis· Forrás

Egyszerre toboroz

Hány vizsgálat toboroz itt egyszerre ugyanarra az indikációra. Darabszám, nem értékelés.

• Crohn-betegség2 toboroz
• Amiotrófiás laterálszklerózis (ALS)1 toboroz
• Colitis ulcerosa1 toboroz
• Diffúz nagy B-sejtes limfóma (DLBCL)1 toboroz
• Fej-nyaki daganatok1 toboroz
• Follikuláris limfóma1 toboroz
• Glioblasztóma1 toboroz
• Hodgkin-limfóma1 toboroz
• Idiopátiás tüdőfibrózis1 toboroz
• Köpenysejtes limfóma1 toboroz
• Máj- és epeúti rák1 toboroz
• Stroke (szélütés)1 toboroz
• Vesedaganat1 toboroz

Kutatók

Ide még nem kötődik kutató.

Lezárt vizsgálatok

• Leállították

  A Phase 1-1b Study to Evaluate the Safety, Efficacy and Dosimetry of Study Drug A9-3408 in Subjects With Metastatic Melanoma

  NCT07076550· 1. fázis· Forrás

• Lezárult

  A Trial of SHR-1707 Infusion in Patients With Mild Cognitive Impairment Due to Alzheimer's Disease and Mild Alzheimer's Disease

  NCT06114745· 1. fázis· Forrás

• Leállították

  The Present Study Aims to Compare Patients Who Receive the Investigational Product (177Lu-DOTA-rosopatamab) Plus Standard of Care, in Comparison to Standard of Care Only

  NCT04876651· 3. fázis· Forrás

• Lezárult

  Multinational Study of Efficacy and Safety of Inhaled Treprostinil in Subjects With Idiopathic Pulmonary Fibrosis

  NCT05255991· 3. fázis· Forrás

• Toboroz

  Clinical Trial of YH32367 in Patients With HER2 Positive Locally Advanced or Metastatic Solid Tumor

  NCT05523947· 1/2. fázis· Forrás

• Toboroz

  Bone Loss Prevention With Zoledronic Acid or Denosumab in Critically Ill Adults

  NCT04608630· 2. fázis· Forrás

• Lezárult

  RegoNivo vs Standard of Care Chemotherapy in AGOC

  NCT04879368· 3. fázis· Forrás

• Lezárult

  OLE of Phase 2b/3 Study ANAVEX2-73-AD-004

  NCT04314934· 2/3. fázis· Forrás

• Lezárult

  Palbociclib, Letrozole & Venetoclax in ER and BCL-2 Positive Breast Cancer

  NCT03900884· 1. fázis· Forrás